Status:
WITHDRAWN
Turmeric as Treatment in Epilepsy
Lead Sponsor:
NYU Langone Health
Conditions:
Epilepsy
Dravet Syndrome
Eligibility:
All Genders
1-70 years
Phase:
NA
Brief Summary
This is a single center open-label pilot clinical trial of patients 1-70 years of age with greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis...
Eligibility Criteria
Inclusion
- Patients with greater than greater than six seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures followed at NYU CEC.
Exclusion
- Patients expected to have changes to any medications or supplements during study period
- exposure to any investigational agent in the month prior to study entry
- pregnant or breast feeding women, positive pregnancy test
- history of non-compliance
- known drug or alcohol dependence
- known baseline hematologic
- liver function
- renal function
- absorption
- absorption
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03254680
Start Date
March 1 2018
End Date
November 1 2018
Last Update
April 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016